Beta-1,4-galactosyltransferase deficiency (Q90009): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Changed label, description and/or aliases in pt-br, en
‎Changed an Item
 
(5 intermediate revisions by the same user not shown)
Property / Canonical URI
 
Property / Canonical URI: https://id.who.int/icd/entity/2127970541 / rank
 
Normal rank
Property / CURIE
 
CID11:ID_2127970541
Property / CURIE: CID11:ID_2127970541 / rank
 
Normal rank
Property / Canary Token
 
dki-india-ID_2127970541
Property / Canary Token: dki-india-ID_2127970541 / rank
 
Normal rank
Property / Verification Status
 
Concluído
Property / Verification Status: Concluído / rank
 
Normal rank
Property / Knowledge Architect
 
Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank
 
Normal rank
Property / Collection date
 
13 August 2026
Timestamp+2026-08-13T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / Collection date: 13 August 2026 / rank
 
Normal rank

Latest revision as of 16:56, 15 August 2026

The CDG (Congenital Disorders of Glycosylation) syndromes are a group of autosomal recessive disorders affecting glycoprotein synthesis. CDG syndrome type IId is characterised by macrocephaly due to Dandy-Walker malformation, hydrocephaly, hypotonia, myopathy and coagulation anomalies. To date, only one case has been reported. The syndrome is associated with mutations in the GALT1 gene (localised to region q13 of chromosome 9) leading to a deficiency in the Golgi apparatus enzyme beta-1,4-galactosyl transferase.
Language Label Description Also known as
default for all languages
ID_2127970541
    English
    Beta-1,4-galactosyltransferase deficiency
    The CDG (Congenital Disorders of Glycosylation) syndromes are a group of autosomal recessive disorders affecting glycoprotein synthesis. CDG syndrome type IId is characterised by macrocephaly due to Dandy-Walker malformation, hydrocephaly, hypotonia, myopathy and coagulation anomalies. To date, only one case has been reported. The syndrome is associated with mutations in the GALT1 gene (localised to region q13 of chromosome 9) leading to a deficiency in the Golgi apparatus enzyme beta-1,4-galactosyl transferase.

      Statements

      CID11:ID_2127970541
      0 references
      dki-india-ID_2127970541
      0 references
      Concluído
      0 references
      13 August 2026
      0 references